FREE LIVE CE for GSHP Members!
Webinar-
Tuesday, January 23, 2024 – 7:00pm-8:00 pm
Am I Losing it? Tirzepatide: A New Indication for Weight Loss
Presenter:
Lina Cummings, PharmD,
PGY-1 Pharmacy Resident,
Phoebe Putney Memorial Hospital
Objectives:
Pharmacist Learning Objectives
- Describe the burden of obesity in the United States.
- Discuss the current guideline recommendations for obesity management.
- Compare the pharmacology of novel tirzepatide, Zepbound, to other injectable weight loss medications on the market.
- Evaluate recent literature supporting the role of tirzepatide for chronic weight management in adults with obesity.
Pharmacy Technician Learning Objectives
- Describe the burden of obesity in the United States.
- List the current guideline recommendations for obesity management.
- Compare the novel tirzepatide, Zepbound, to other injectable weight loss medications on the market.
This is a knowledge based activity
0228-9999-24-016-L01-P
0228-9999-24-016-L01-T
This is a member service of GSHP. There is no charge for members to attend. Dues must be current to receive CE credit.
Non-members will be charged $20 for CE processing
To register: https://us02web.zoom.us/webinar/register/WN_Y5qzFc5ETlCs-Zzp1EdeFQ
Georgia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
